Market Place
Sourcing Support
Aspen Neuroscience Advances Cell Therapy for Parkinson`s Disease
10 Jan 2025 //
PR NEWSWIRE
Mytos & Aspen Partner On Parkinson Disease Cell Therapy Automation
08 Jan 2025 //
CONTRACTPHARMA
Aspen Neuroscience Showcases Advances In Autologous Cell Therapy
07 Oct 2024 //
PR NEWSWIRE
Aspen Neuroscience levels up in-house cell therapy production
02 Oct 2024 //
FIERCE PHARMA
ClearPoint Neuro Celebrates Partner Aspen Neuroscience Using ClearPoint® System
20 Jun 2024 //
GLOBENEWSWIRE
Aspen Neuroscience to Present at 2023 Cell & Gene Meeting on the Mesa
09 Oct 2023 //
PR NEWSWIRE
Aspen Neuroscience Announces FDA Clearance of Investigational NDA for ANPD001
08 Aug 2023 //
PR NEWSWIRE
Beam takes time to clinic;Aspen gets clearance to test Parkinson`s cell therapy
08 Aug 2023 //
ENDPTS
Kim Raineri Joins Aspen Neuroscience as CTO
19 Oct 2022 //
BIOSPACE
Aspen Reels in $147.5M to Advance Personalized Parkinson`s Therapy
10 May 2022 //
BIOSPACE
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience
13 Jul 2021 //
PRNEWSWIRE
Rushing against a pandemic clock, Aspen Neurosciences secures $70M Series A
01 Apr 2020 //
ENDPTS
Aspen Neuroscience Launches With $6.5 Million Seed Funding
12 Dec 2019 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.